MEFV Mutations in Egyptian Children with Systemic-Onset Juvenile Idiopathic Arthritis
- 93 Downloads
Background and Objectives
Systemic-onset juvenile idiopathic arthritis (SoJIA) is a chronic auto-inflammatory disease of childhood, with a complex genetic trait, which is characterized by arthritis associated with systemic manifestations. Familial Mediterranean fever (FMF) is another auto-inflammatory disorder that is monogenic. There are speculations as to whether Mediterranean fever (MEFV) mutations are among the genetic determinants of SoJIA. Our aim was to explore the frequency and clinical significance of MEFV mutations in Egyptian SoJIA patients. A group of healthy children were assigned to the control group in an attempt to estimate the carrier rate of MEFV mutations in Egypt.
Eighty-four children were recruited in this study; 54 children, age (mean ± standard deviation; 8.31 ± 2.85 years), diagnosed as having SoJIA with no typical symptoms of FMF; 30 healthy age- and gender-matched children served as the control group. All recruited children were screened for 12 common MEFV mutations using a reverse hybridization assay of biotinylated PCR products.
SoJIA patients had a significantly higher frequency of MEFV mutations (66.7 %) than in the healthy control population (16.7 %). V726A was the leading mutation in SoJIA patients, with an allelic frequency of 15.74 %, followed by E148Q, with an allelic frequency of 7.4 %. Children who were carriers of MEFV mutations had an 18 times higher risk of developing SoJIA than wild-type carriers [odds ratio 18.0 (95 % CI 5–69), P < 0.01]. E148Q was the leading mutation, present in 13.3 % of healthy controls.
These findings suggest that MEFV mutations may be responsible for auto-inflammatory diseases other than FMF, and patients with SoJIA, especially those with a positive family history of FMF or SoJIA, should be screened for MEFV mutations in countries where FMF is frequent.
KeywordsJuvenile Idiopathic Arthritis Familial Mediterranean Fever Familial Mediterranean Fever Patient Time High Risk MEFV Gene
Acknowledgments and Disclosures
Special thanks to all Rheumatology Clinic members, who helped us in our work, and to our dear patients, who participated in conducting the study. The authors have no conflicts of interest that are directly relevant to the content of this article.
- 5.Lovell DJ. Update on treatment of arthritis in children—new treatments, new goals. Bull Hosp Jt Dis. 2006;64:72–6.Google Scholar
- 22.Infevers: an online database for autoinflammatory mutations. http://fmf.igh.cnrs.fr/ISSAID/infevers/. Accessed 11 Jan 2014. Milhavet F, Cuisset L, Hoffman HM, et al. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat. 2008;29(6):803–8. doi: 10.1002/humu.20720.PMID:18409191.
- 35.Settin A, El-Baz R, Abd Rasool M, et al. Clinical and molecular diagnosis of familial Mediterranean fever in Egyptian children. J Gastrointest Liver Dis. 2007;16(2):141–5.Google Scholar
- 39.Temtamy SA, Aglan MS, Meguid NA, Teebi AS. Chapter 8: genetic disorders in Egypt. In: Teebi AS, editor. Genetic disorders among Arab populations. 2nd ed. Heidelberg: Springer; 2010. doi: 10.1007/978-3-642-05080-0_8.